Kalaris Therapeutics, Inc. (KLRS) — Financial Flexibility Index
Kalaris Therapeutics, Inc. (KLRS) has a Financial Flexibility Index of -0.32x as of March 2026. Free cash flow of $-13.35 Million (operating CF $-13.35 Million minus capex $0.00) represents 0% of total liabilities ($41.25 Million). Check Kalaris Therapeutics, Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kalaris Therapeutics, Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Kalaris Therapeutics, Inc. across 8 annual periods. For the full cash flow conversion analysis, see Kalaris Therapeutics, Inc. (KLRS) cash conversion ratio.
Annual Financial Flexibility Index for Kalaris Therapeutics, Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for Kalaris Therapeutics, Inc.. Explore debt repayment capacity of Kalaris Therapeutics, Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | $-42.78 Million | $-42.98 Million | $42.92 Million | ▲ +92.3% |
| 2024 | -12.92x | $-67.70 Million | $-67.70 Million | $5.24 Million | ▼ -4321.5% |
| 2023 | -0.29x | $-14.13 Million | $-14.13 Million | $48.35 Million | ▼ -2.1% |
| 2022 | -0.29x | $-9.78 Million | $-9.78 Million | $34.17 Million | ▲ +83.5% |
| 2021 | -1.73x | $-106.29 Million | $-106.32 Million | $61.33 Million | ▲ +49.2% |
| 2020 | -3.41x | $-60.58 Million | $-60.81 Million | $17.76 Million | ▼ -206.4% |
| 2019 | -1.11x | $-19.82 Million | $-20.16 Million | $17.80 Million | ▼ -314.1% |
| 2018 | 0.52x | $1.94 Million | $1.94 Million | $3.74 Million | — |